CTH, cystathionine gamma-lyase, 1491

N. diseases: 93; N. variants: 5
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C1846460
Disease: Abnormality of the outer ear
Abnormality of the outer ear
0.100 Biomarker disease HPO
CUI: C0000833
Disease: Abscess
Abscess
0.010 AlteredExpression phenotype BEFREE Streptococcus anginosus l-cysteine desulfhydrase gene expression is associated with abscess formation in BALB/c mice. 21545699 2011
CUI: C0001339
Disease: Acute pancreatitis
Acute pancreatitis
0.010 AlteredExpression disease BEFREE Protein steady-state levels of S-adenosylhomocysteine-hydrolase and cystathionine gamma-lyase diminished but methylthioadenosine phosphorylase levels increased in pancreas with acute pancreatitis. 31539805 2020
CUI: C0206681
Disease: Adenocarcinoma, Clear Cell
Adenocarcinoma, Clear Cell
0.010 Biomarker disease BEFREE In a proteomic screen, we identified cystathionine γ-lyase (CTH) as a marker for clear cell carcinoma, as it is expressed at high levels in clear cell carcinomas of the ovary and endometrium. 28678427 2017
CUI: C0278878
Disease: Adult Glioblastoma
Adult Glioblastoma
0.010 Biomarker disease BEFREE Erastin sensitizes glioblastoma cells to temozolomide by restraining xCT and cystathionine-γ-lyase function. 25585997 2015
CUI: C0699949
Disease: airway disease
airway disease
0.010 GeneticVariation disease BEFREE We used mice genetically deficient in the cystathionine γ-lyase enzyme (CSE), the major H<sub>2</sub>S-generating enzyme in the lung to determine the contribution of H<sub>2</sub>S to airway disease in response to side-stream tobacco smoke (TS), and to TS/RSV co-exposure. 30986815 2019
CUI: C0155877
Disease: Allergic asthma
Allergic asthma
0.010 AlteredExpression disease BEFREE The aim of the present study is to examine whether the age-dependent development of allergic asthma is caused by age-dependent expression of cystathionine gamma-lyase (CSE), a key enzyme that catalyzes the production of hydrogen sulfide (H<sub>2</sub>S). 28253731 2017
CUI: C0003504
Disease: Aortic Valve Insufficiency
Aortic Valve Insufficiency
0.010 Biomarker disease BEFREE Lowering endogenous production of H<sub>2</sub> S by concomitant silencing of cystathionine γ-lyase (CSE) and cystathionine β-synthase (CBS) favoured VIC calcification. analysis of human specimens revealed higher Expression of CSE in aorta stenosis valves with calcification (AS) was higher than in valves of aortic insufficiency (AI). 31017307 2020
CUI: C0003507
Disease: Aortic Valve Stenosis
Aortic Valve Stenosis
0.010 Biomarker disease BEFREE Lowering endogenous production of H<sub>2</sub> S by concomitant silencing of cystathionine γ-lyase (CSE) and cystathionine β-synthase (CBS) favoured VIC calcification. analysis of human specimens revealed higher Expression of CSE in aorta stenosis valves with calcification (AS) was higher than in valves of aortic insufficiency (AI). 31017307 2020
CUI: C0003578
Disease: Apnea
Apnea
0.010 Biomarker phenotype BEFREE Blocking the CB hyperactivity with L-propargylglycine, an inhibitor of cystathionine-γ-lyase (CSE), which catalyzes H<sub>2</sub>S synthesis, prevented apneas in HO-2<sup>-/-</sup> mice. 30357741 2019
CUI: C0003850
Disease: Arteriosclerosis
Arteriosclerosis
0.040 Biomarker disease BEFREE We previously reported that cystathionine γ-lyase knockout (CSE-KO) male mice develop atherosclerosis earlier than male wild-type (WT) mice. 27986657 2017
CUI: C0003850
Disease: Arteriosclerosis
Arteriosclerosis
0.040 Biomarker disease BEFREE Cystathionine γ lyase (CSE) is the major source of hydrogen sulfide-derived species (H<sub>2</sub>S<sub>n</sub>) in endothelial cells and plays an important role in protecting against atherosclerosis. 31759247 2020
CUI: C0003850
Disease: Arteriosclerosis
Arteriosclerosis
0.040 Biomarker disease BEFREE Therefore, we aimed to evaluate the involvement of hydrogen sulfide (H <sub>2</sub> S)/cystathionine γ-lyase (CSE) in the pathogenesis of AS as well as their possible signaling pathways. 30246263 2019
CUI: C0003850
Disease: Arteriosclerosis
Arteriosclerosis
0.040 AlteredExpression disease BEFREE Inhibition of HDAC6 activity may improve endothelial function and prevent or reverse the development of atherosclerosis.<b>NEW & NOTEWORTHY</b> Oxidative injury to endothelial cells by oxidized LDL reduced cystathionine γ-lyase (CSEγ) expression and H<sub>2</sub>S production, leading to endothelial dysfunction, which was prevented by histone deacetylase 6 (HDAC6) inhibition. 28188215 2017
CUI: C0004114
Disease: Astrocytoma
Astrocytoma
0.010 AlteredExpression disease BEFREE The present study investigated the effect of cystathionine on astrocytoma (U373) cell proliferation, the activity of γ-cystathionase (CTH) and changes in thiols levels. 29848703 2018
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis
0.040 AlteredExpression disease BEFREE Inhibition of HDAC6 activity may improve endothelial function and prevent or reverse the development of atherosclerosis.<b>NEW & NOTEWORTHY</b> Oxidative injury to endothelial cells by oxidized LDL reduced cystathionine γ-lyase (CSEγ) expression and H<sub>2</sub>S production, leading to endothelial dysfunction, which was prevented by histone deacetylase 6 (HDAC6) inhibition. 28188215 2017
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis
0.040 Biomarker disease BEFREE Therefore, we aimed to evaluate the involvement of hydrogen sulfide (H <sub>2</sub> S)/cystathionine γ-lyase (CSE) in the pathogenesis of AS as well as their possible signaling pathways. 30246263 2019
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis
0.040 Biomarker disease BEFREE We previously reported that cystathionine γ-lyase knockout (CSE-KO) male mice develop atherosclerosis earlier than male wild-type (WT) mice. 27986657 2017
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis
0.040 Biomarker disease BEFREE Cystathionine γ lyase (CSE) is the major source of hydrogen sulfide-derived species (H<sub>2</sub>S<sub>n</sub>) in endothelial cells and plays an important role in protecting against atherosclerosis. 31759247 2020
CUI: C4703473
Disease: Atherosclerotic lesion
Atherosclerotic lesion
0.010 AlteredExpression disease BEFREE This study provides new insights into the interaction of H<sub>2</sub>S and estrogen signaling pathways on the regulation of cardiovascular functions.<b>NEW & NOTEWORTHY</b> Female cystathionine γ-lyase (CSE)-knockout mice have significantly lower plasma estrogen levels and more severe early atherosclerotic lesion than female wild-type mice. 27986657 2017
CUI: C0005695
Disease: Bladder Neoplasm
Bladder Neoplasm
0.010 GeneticVariation disease BEFREE Additional work is needed to comprehensively evaluate genomic variation in CTH and related genes in the trans-sulfuration pathway and bladder cancer risk. 17311259 2007
CUI: C0232849
Disease: Bladder pain
Bladder pain
0.030 Biomarker phenotype BEFREE The enhanced Ca<sub>v</sub>3.2 activity by H<sub>2</sub>S formed by the upregulated cystathionine-γ-lyase (CSE) is involved in the cyclophosphamide (CPA)-induced cystitis-related bladder pain in mice. 29129814 2018
CUI: C0232849
Disease: Bladder pain
Bladder pain
0.030 AlteredExpression phenotype BEFREE Involvement of NF-κB in the upregulation of cystathionine-γ-lyase, a hydrogen sulfide-forming enzyme, and bladder pain accompanying cystitis in mice. 29044685 2018
CUI: C0232849
Disease: Bladder pain
Bladder pain
0.030 Biomarker phenotype BEFREE Involvement of the cystathionine-γ-lyase/Ca<sub>v</sub>3.2 pathway in substance P-induced bladder pain in the mouse, a model for nonulcerative bladder pain syndrome. 29407215 2018
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma
0.030 AlteredExpression disease BEFREE Cystathionine γ-lyase (CSE) is highly expressed in breast cancer, and can promote breast cancer development and progression; therefore, inhibitors of CSE may be of great significance for the treatment of breast cancer. 30365149 2019